Omega-3 Fatty Acids and Subconcussive Head Impacts
NCT06736925 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 208
Last updated 2026-04-29
Summary
The purpose of the proposed double-blind, randomized placebo-controlled trial is to understand how supplementation with fish oil \[docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA)\] promote brain health against soccer heading. The study involves taking DHA+EPA or placebo, questionnaires, blood draws, brain imaging, tests to evaluate heart function, and soccer headings.
Conditions
- Subconcussive Head Impact
- Omega-3 Fatty Acids
Interventions
- DIETARY_SUPPLEMENT
-
Omega-3 Fatty Acids (EPA plus DHA)
DHA+EPA capsules contain purified deep-sea fish oil, made from 100% wild-caught sardines and anchovies with a 3-year shelf life. The capsule shell is made from bovine limed bone with a size of 20 oblongs. Each soft gel capsule contains 480 mg of DHA, 205 mg of EPA, 145 mg of other omega-3 FA, and 10 mg of vitamin E. Participants in the DHA+EPA group will ingest 5 capsules daily \[a total of 3.4 g/d: DHA (2.4 g), EPA (1.0 g)\].
- DIETARY_SUPPLEMENT
-
Organic soybean oil
We will use organic soybean oil pills ) as a placebo condition for the DHA+EPA group. One capsule contains 485 mg of organic soybean oil, including negligible amounts of DHA (1.1 mg), EPA (1.7 mg), and vitamin E (10 mg). Participants will ingest 5 capsules daily. Soybean oil is one of the most widely used vegetable oils in the world. Soybean oil contains polyunsaturated fats and 18-carbon omega-3 FA (total omega-3 FA of 73.9 mg per capsule), but very low levels of DHA and EPA, which makes it an excellent placebo counterpart when evaluating the effects of DHA/EPA. The placebo capsule's shelf life, composition, shape, size as the DHA+EPA active comparator.
- OTHER
-
Soccer Heading Model
A standardized and reliable soccer heading protocol will be used for the experiment. A triaxial accelerometer (G-force tracker) embedded in a head-band pocket and positioned directly below the external occipital protuberance (inion) to monitor linear and rotational head accelerations. A JUGS soccer machine will be used to simulate a soccer throw-in with a standardized ball speed of 30 mph. The ball speed is similar to when soccer players make a long throw-in from the sideline to mid-field. Soccer players frequently perform this maneuver during practice and games. Subjects will stand approximately 40ft away from the machine to perform the heading. Participants perform 20 headers with 1 header per 30 seconds. The subjects will be instructed to direct the ball back toward the JUGS soccer machine in the air.
Sponsors & Collaborators
-
National Institute of Neurological Disorders and Stroke (NINDS)
collaborator NIH -
Indiana University
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 30 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2025-02-28
- Primary Completion
- 2029-05-31
- Completion
- 2029-05-31
Countries
- United States
Study Locations
More Related Trials
-
DHA For The Treatment of Pediatric Concussion Related to Sports Injury
NCT01903525 ·Status: COMPLETED ·Phase: PHASE1
-
Derivatives of Omega-3 HUFA as Biomarkers of Traumatic Brain Injury
NCT02990091 ·Status: WITHDRAWN ·Phase: PHASE2
-
26 Weeks' Dietary Supplementation With DHA- and EPA-enriched Oils on Cerebral Blood Flow in Healthy Adults
NCT03158545 ·Status: COMPLETED ·Phase: NA
-
Omega-3 Fatty Acids for Treating Adults With Major Depression
NCT00517036 ·Status: COMPLETED ·Phase: PHASE3
-
OPTIMA-TBI Pilot Study
NCT03345550 ·Status: TERMINATED ·Phase: PHASE2
-
Polyunsaturated Fatty Acids for Adjunctive Treatment of Refractory Epilepsy
NCT00299533 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of Omega-3 Fatty Acids Supplementation on Brain and Behaviour in Healthy Children.
NCT02346773 ·Status: COMPLETED ·Phase: NA
-
Lipoic Acid and Omega-3 Fatty Acids for Alzheimer's Disease
NCT01058941 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Fish Oil Brain Delivery Study
NCT02541929 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
The Efficacy of Omega-3 Fatty Acids in Maintaining Optimal Mental Health in Elderly People
NCT00124852 ·Status: COMPLETED ·Phase: NA
-
Omega-3 Supplementation for Pediatric Migraine
NCT06899074 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Safety and Effectiveness of Omega 3-Fatty Acids, EPA Versus DHA, for the Treatment of Major Depression
NCT00361374 ·Status: COMPLETED ·Phase: PHASE3
-
n-3 PUFA for Vascular Cognitive Aging
NCT01953705 ·Status: UNKNOWN ·Phase: PHASE2
-
Omega-3 Fatty Acids and/or Multi-domain Intervention in the Prevention of Age-related Cognitive Decline
NCT00672685 ·Status: COMPLETED ·Phase: NA
-
Effect of 8-Week Dietary DHA Supplementation on Cerebral Blood Flow and Metabolic Function
NCT00662142 ·Status: COMPLETED ·Phase: PHASE3
-
The Role Of Omega-3 Fatty Acids In Adolescent Depression
NCT00962598 ·Status: COMPLETED ·Phase: PHASE2
-
Preliminary Study of Fish Oil and Dementia
NCT00628017 ·Status: COMPLETED ·Phase: NA
-
Omega-3 Fatty Acids in Tourette's Disorder
NCT01315327 ·Status: COMPLETED ·Phase: NA
-
DHA (Docosahexaenoic Acid), an Omega 3 Fatty Acid, in Slowing the Progression of Alzheimer's Disease
NCT00440050 ·Status: COMPLETED ·Phase: PHASE3
-
Citicoline and Omega-3 Fatty Acid Effects in Veterans With Traumatic Brain Injury (TBI)
NCT01515917 ·Status: WITHDRAWN ·Phase: NA
-
Docosahexaenoic Acid in the Treatment of Autism
NCT00577447 ·Status: COMPLETED ·Phase: NA
-
Fish Oil (Omega 3), Immune Function, and Mood
NCT00385723 ·Status: COMPLETED ·Phase: PHASE2
-
Omega-3 Fatty Acids in Adolescent Depression
NCT00312897 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Docosahexaenoic Acid (DHA)-Rich Fish Oil on Cerebral Haemodynamics
NCT01075932 ·Status: COMPLETED ·Phase: NA
-
26 Weeks' Dietary Supplementation With DHA- and EPA-enriched Oils on Memory Consolidation in Healthy Adults
NCT03592251 ·Status: COMPLETED ·Phase: NA